NASDAQ : NEO
NeoGenomics, Inc. — Financial statements
Healthcare · Diagnostics & Research · United States
Last price 17.93 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.30B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
NeoGenomics, Inc. (NEO) reported revenue of 787.75M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 787.75M | 727.33M | 660.57M | 591.64M | 509.73M | 484.33M |
| Cost of Revenue | 435.08M | 413.44M | 370.47M | 347.04M | 321.83M | 297.27M |
| Gross Profit | 352.67M | 313.89M | 290.10M | 244.60M | 187.90M | 187.06M |
| Selling, General & Admin | 356.47M | 346.46M | 330.04M | 313.94M | 310.68M | 283.94M |
| Research & Development | 39.33M | 37.08M | 31.16M | 27.31M | 30.33M | 21.87M |
| Operating Expenses | 395.80M | 383.54M | 361.19M | 341.25M | 341.00M | 305.81M |
| Operating Income | -43.13M | -69.64M | -71.09M | -96.65M | -153.11M | -118.75M |
| Interest Expense | -3.25M | -3.75M | -6.62M | -6.91M | -7.58M | -8.22M |
| Interest & Investment Income | 5.21M | 9.07M | 18.43M | 16.90M | 6.08M | 112.40M |
| Other Non Operating Income (Expenses) | 46.00K | 296.00K | -379.00K | 644.00K | -213.00K | -499.00K |
| EBT Excluding Unusual Items | -41.12M | -64.03M | -59.66M | -86.01M | -154.83M | -15.07M |
| Merger & Restructuring Charges | -4.70M | -4.70M | -6.66M | -11.09M | -4.52M | |
| Impairment of Goodwill | -3.50M | |||||
| Asset Writedown | -626.00K | -23.85M | ||||
| Legal Settlements | -413.00K | -11.28M | -13.75M | |||
| Other Unusual Items | 10.68M | -2.90M | -600.00K | |||
| Pretax Income | -36.18M | -110.27M | -80.67M | -97.10M | -159.34M | -15.07M |
| Income Tax Expense | -3.88M | -2.24M | -1.95M | -9.13M | -15.09M | -6.73M |
| Net Income | -32.30M | -108.03M | -78.73M | -87.97M | -144.25M | -8.35M |
| Net Income to Common | -32.30M | -108.03M | -78.73M | -87.97M | -144.25M | -8.35M |
| Shares Outstanding (Basic) | 129.01M | 128.10M | 126.66M | 125.50M | 124.22M | 119.96M |
| Shares Outstanding (Diluted) | 129.01M | 128.10M | 126.66M | 125.50M | 124.22M | 119.96M |
| EPS (Basic) | -0.25 | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 |
| EPS (Diluted) | -0.25 | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 |
| Free Cash Flow | -28.58M | -21.78M | -34.04M | -30.70M | -96.88M | -90.86M |
| Free Cash Flow Per Share | -0.22 | -0.17 | -0.27 | -0.24 | -0.78 | -0.76 |
| Gross Margin | 44.77% | 43.16% | 43.92% | 41.34% | 36.86% | 38.62% |
| Operating Margin | -5.47% | -9.57% | -10.76% | -16.34% | -30.04% | -24.52% |
| Profit Margin | -4.10% | -14.85% | -11.92% | -14.87% | -28.30% | -1.72% |
| Free Cash Flow Margin | -3.63% | -2.99% | -5.15% | -5.19% | -19.01% | -18.76% |
| EBITDA | 22.76M | -1.82M | 1.45M | -24.07M | -83.68M | -65.40M |
| EBITDA Margin | 2.89% | -0.25% | 0.22% | -4.07% | -16.42% | -13.50% |
| D&A For EBITDA | 65.89M | 67.82M | 72.55M | 72.58M | 69.43M | 53.35M |
| EBIT | -43.13M | -69.64M | -71.09M | -96.65M | -153.11M | -118.75M |
| EBIT Margin | -5.47% | -9.57% | -10.76% | -16.34% | -30.04% | -24.52% |
| Revenue as Reported | 484.33M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 139.28M | 159.62M | 367.01M | 342.49M | 263.18M | 316.83M |
| Short-Term Investments | 19.83M | 72.72M | 174.81M | 198.56M | ||
| Cash & Short-Term Investments | 139.28M | 159.62M | 386.84M | 415.20M | 437.99M | 515.39M |
| Receivables | 213.41M | 159.24M | 150.64M | 131.26M | 121.61M | 113.87M |
| Inventory | 25.50M | 28.57M | 26.75M | 24.16M | 24.28M | 23.39M |
| Prepaid Expenses | 22.77M | 21.44M | 20.16M | 17.99M | 15.24M | 12.35M |
| Other Current Assets | 9.12M | 7.42M | 11.62M | 8.20M | 6.18M | 16.50M |
| Total Current Assets | 410.08M | 376.29M | 596.02M | 596.81M | 605.29M | 681.51M |
| Property, Plant & Equipment | 170.21M | 163.28M | 173.69M | 183.78M | 198.61M | 211.66M |
| Goodwill | 524.00M | 524.34M | 522.77M | 522.77M | 522.77M | 527.12M |
| Other Intangible Assets | 263.63M | 286.53M | 339.68M | 373.13M | 408.26M | 442.32M |
| Long-Term Accounts Receivable | 31.00K | 236.00K | ||||
| Long-Term Deferred Charges | 170.00K | 36.00K | 11.00K | 53.00K | 715.00K | 882.00K |
| Other Long-Term Assets | 8.83M | 9.36M | 5.88M | 4.69M | 4.36M | 6.05M |
| Total Assets | 1.38B | 1.36B | 1.64B | 1.68B | 1.74B | 1.87B |
| Accounts Payable | 32.92M | 23.09M | 21.61M | 20.33M | 20.51M | 17.92M |
| Accrued Expenses | 76.98M | 59.58M | 75.07M | 68.23M | 55.21M | 53.10M |
| Current Portion of Long-Term Debt | 200.78M | 70.00K | 1.14M | |||
| Current Portion of Leases | 6.00M | 4.78M | 3.38M | 5.61M | 6.58M | 6.88M |
| Current Unearned Revenue | 267.00K | 851.00K | 409.00K | 2.13M | 7.56M | 5.19M |
| Other Current Liabilities | 3.00M | |||||
| Total Current Liabilities | 116.17M | 88.30M | 301.24M | 96.30M | 89.93M | 87.23M |
| Long-Term Debt | 374.69M | 341.86M | 340.33M | 538.20M | 535.32M | 532.48M |
| Long-Term Leases | 68.45M | 62.82M | 60.84M | 67.87M | 68.95M | 72.29M |
| Long-Term Unearned Revenue | 357.00K | 386.00K | 336.00K | 19.00K | 917.00K | |
| Long-Term Deferred Tax Liabilities | 16.10M | 18.22M | 21.51M | 24.29M | 34.75M | 55.48M |
| Other Long-Term Liabilities | 510.00K | 11.68M | 11.44M | 13.03M | 13.04M | 13.11M |
| Total Liabilities | 576.28M | 523.27M | 735.70M | 739.69M | 742.01M | 761.50M |
| Common Stock | 131.00K | 129.00K | 128.00K | 127.00K | 127.00K | 124.00K |
| Additional Paid-In Capital | 1.28B | 1.27B | 1.23B | 1.19B | 1.16B | 1.12B |
| Retained Earnings | -456.22M | -433.81M | -325.78M | -247.06M | -159.09M | -14.84M |
| Comprehensive Income & Other | 4.00K | 4.00K | -206.00K | -1.67M | -3.90M | -638.00K |
| Total Common Equity | 800.64M | 836.56M | 902.34M | 941.54M | 998.02M | 1.11B |
| Shareholders' Equity | 800.64M | 836.56M | 902.34M | 941.54M | 998.02M | 1.11B |
| Total Liabilities & Equity | 1.38B | 1.36B | 1.64B | 1.68B | 1.74B | 1.87B |
| Total Debt | 449.14M | 409.46M | 605.33M | 611.68M | 610.93M | 612.79M |
| Net Cash (Debt) | -309.86M | -249.84M | -218.49M | -196.48M | -172.94M | -97.40M |
| Net Cash Per Share | -2.40 | -1.95 | -1.73 | -1.57 | -1.39 | -0.81 |
| Filing Date Shares Outstanding | 129.39M | 129.81M | 128.46M | 127.61M | 127.46M | 124.03M |
| Total Common Shares Outstanding | 129.10M | 128.99M | 128.15M | 127.37M | 126.91M | 124.11M |
| Working Capital | 293.91M | 287.99M | 294.78M | 500.51M | 515.36M | 594.28M |
| Book Value Per Share | 6.20 | 6.49 | 7.04 | 7.39 | 7.86 | 8.93 |
| Tangible Book Value | 13.02M | 25.69M | 39.89M | 45.64M | 67.00M | 138.84M |
| Tangible Book Value Per Share | 0.10 | 0.20 | 0.31 | 0.36 | 0.53 | 1.12 |
| Machinery | 148.05M | 147.43M | 142.03M | 136.88M | 127.94M | |
| Construction In Progress | 7.73M | 8.51M | 3.61M | 8.98M | 12.39M | |
| Leasehold Improvements | 59.41M | 57.57M | 49.23M | 44.42M | 43.25M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -32.30M | -108.03M | -78.73M | -87.97M | -144.25M | -8.35M |
| Depreciation & Amortization | 65.89M | 67.82M | 72.55M | 72.58M | 69.43M | 53.35M |
| Other Amortization | 1.67M | 2.00M | 2.91M | 2.88M | 2.84M | 2.74M |
| Loss (Gain) From Sale of Assets | 31.00K | 31.00K | -49.00K | 292.00K | 810.00K | 606.00K |
| Asset Writedown & Restructuring Costs | 626.00K | 27.35M | 450.00K | 1.70M | 718.00K | 6.06M |
| Loss (Gain) From Sale of Investments | -109.26M | |||||
| Stock-Based Compensation | 34.73M | 41.32M | 33.41M | 24.63M | 24.67M | 22.46M |
| Other Operating Activities | -5.14M | 6.83M | 9.10M | 9.42M | 11.49M | 10.27M |
| Change in Accounts Receivable | -58.38M | -6.18M | -19.31M | -11.52M | -7.58M | -4.69M |
| Change in Inventory | 3.04M | -1.54M | -2.70M | -454.00K | -1.10M | 1.63M |
| Change in Accounts Payable | -6.58M | -4.69M | -4.00M | -4.55M | 958.00K | 7.71M |
| Change in Other Net Operating Assets | 5.50M | -16.32M | -3.55M | 2.22M | -7.88M | -2.96M |
| Operating Cash Flow | 4.28M | 5.23M | 7.02M | -1.95M | -65.99M | -26.72M |
| Capital Expenditures | -32.86M | -27.01M | -41.06M | -28.75M | -30.89M | -64.14M |
| Sale of Property, Plant & Equipment | 2.07M | 2.07M | 12.10M | |||
| Cash Acquisitions | -6.45M | -419.40M | ||||
| Investment in Securities | 19.56M | 53.92M | 105.46M | 19.31M | -133.82M | |
| Other Investing Activities | -675.00K | -500.00K | -15.00M | |||
| Investing Cash Flow | -31.47M | -12.34M | 12.86M | 76.71M | 517.00K | -632.37M |
| Long-Term Debt Issued | 334.41M | |||||
| Long-Term Debt Repaid | -201.25M | -70.00K | -758.00K | -3.05M | ||
| Net Debt Issued (Repaid) | 42.09M | -201.25M | -70.00K | -758.00K | 331.36M | |
| Issuance of Common Stock | 14.83M | 962.00K | 7.50M | 6.67M | 14.16M | 423.21M |
| Other Financing Activities | -28.67M | -2.85M | -2.05M | -1.58M | -29.29M | |
| Financing Cash Flow | 2.32M | -200.29M | 4.65M | 4.55M | 11.83M | 725.28M |
| Net Cash Flow | -24.84M | -207.39M | 24.52M | 79.31M | -53.65M | 66.19M |
| Free Cash Flow | -28.58M | -21.78M | -34.04M | -30.70M | -96.88M | -90.86M |
| Free Cash Flow Margin | -3.63% | -2.99% | -5.15% | -5.19% | -19.01% | -18.76% |
| Free Cash Flow Per Share | -0.22 | -0.17 | -0.27 | -0.24 | -0.78 | -0.76 |
| Levered Free Cash Flow | 4.80M | 17.20M | -1.93M | -272.88K | -30.50M | -64.72M |
| Unlevered Free Cash Flow | 5.17M | 17.55M | -712.38K | 1.17M | -28.60M | -62.32M |
| Cash Interest Paid | 830.00K | 1.69M | 3.83M | 3.38M | 3.40M | 3.06M |
| Cash Income Tax Paid | 768.00K | 515.00K | 207.00K | 175.00K | 180.00K | 148.00K |
| Change in Working Capital | -61.23M | -32.09M | -32.63M | -25.49M | -31.70M | -4.60M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.25B | 1.52B | 2.12B | 2.06B | 1.17B | 4.20B |
| Enterprise Value | 2.56B | 1.77B | 2.33B | 2.27B | 1.34B | 4.27B |
| Last Close Price | 17.38 | 11.76 | 16.48 | 16.18 | 9.24 | 34.12 |
| Forward PE | 61.07 | 83.58 | 103.91 | 266.98 | 266.98 | 266.98 |
| PS Ratio | 2.85 | 2.09 | 3.20 | 3.49 | 2.29 | 8.67 |
| PB Ratio | 2.80 | 1.82 | 2.34 | 2.19 | 1.17 | 3.79 |
| P/TBV Ratio | 172.78 | 59.23 | 53.03 | 45.19 | 17.42 | 30.26 |
| P/OCF Ratio | 525.42 | 290.94 | 301.21 | |||
| PEG Ratio | 1.06 | 1.70 | 6.21 | 6.21 | 6.21 | 6.21 |
| EV/Sales Ratio | 3.25 | 2.43 | 3.53 | 3.83 | 2.62 | 8.82 |
| EV/EBITDA Ratio | 112.40 | 1,607.33 | ||||
| Debt / Equity Ratio | 0.56 | 0.49 | 0.67 | 0.65 | 0.61 | 0.55 |
| Debt / EBITDA Ratio | 14.64 | 52.97 | 45.92 | |||
| Net Debt / Equity Ratio | 0.39 | 0.30 | 0.24 | 0.21 | 0.17 | 0.09 |
| Net Debt / EBITDA Ratio | 13.61 | -137.20 | 150.47 | -8.16 | -2.07 | -1.49 |
| Net Debt / FCF Ratio | -10.84 | -11.47 | -6.42 | -6.40 | -1.78 | -1.07 |
| Asset Turnover | 0.57 | 0.48 | 0.40 | 0.35 | 0.28 | 0.34 |
| Inventory Turnover | 16.13 | 14.95 | 14.55 | 14.33 | 13.50 | 11.23 |
| Quick Ratio | 3.04 | 3.61 | 1.78 | 5.67 | 6.22 | 7.21 |
| Current Ratio | 3.53 | 4.26 | 1.98 | 6.20 | 6.73 | 7.81 |
| Return on Equity (ROE) | -3.94% | -12.42% | -8.54% | -9.07% | -13.70% | -0.93% |
| Return on Assets (ROA) | -1.96% | -2.90% | -2.68% | -3.53% | -5.30% | -5.19% |
| Return on Invested Capital (ROIC) | -3.92% | -6.31% | -6.30% | -8.37% | -12.88% | -13.03% |
| Return on Capital Employed (ROCE) | -3.40% | -5.50% | -5.30% | -6.10% | -9.30% | -6.70% |
| Earnings Yield | -1.44% | -7.10% | -3.72% | -4.26% | -12.36% | -0.20% |
| FCF Yield | -1.27% | -1.43% | -1.61% | -1.49% | -8.30% | -2.16% |
| Buyback Yield / Dilution | -1.00% | -1.14% | -0.92% | -1.03% | -3.55% | -7.31% |